Literature DB >> 21148398

Nanomedicine in GI.

Hamed Laroui1, David S Wilson, Guillaume Dalmasso, Khalid Salaita, Niren Murthy, Shanthi V Sitaraman, Didier Merlin.   

Abstract

Recent advances in nanotechnology offer new hope for disease detection, prevention, and treatment. Nanomedicine is a rapidly evolving field wherein targeted therapeutic approaches using nanotechnology based on the pathophysiology of gastrointestinal diseases are being developed. Nanoparticle vectors capable of delivering drugs specifically and exclusively to regions of the gastrointestinal tract affected by disease for a prolonged period of time are likely to significantly reduce the side effects of existing otherwise effective treatments. This review aims at integrating various applications of the most recently developed nanomaterials that have tremendous potential for the detection and treatment of gastrointestinal diseases.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21148398      PMCID： PMC3064120          DOI： 10.1152/ajpgi.00466.2010

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN： 0193-1857            Impact factor:   4.052


  108 in total

1.  Targeted delivery of chitosan nanoparticles to Peyer's patch using M cell-homing peptide selected by phage display technique.

Authors:  Mi-Kyong Yoo; Sang-Kee Kang; Jin-Huk Choi; In-Kyu Park; Hee-Sam Na; Hyun-Chul Lee; Eun-Bae Kim; Nam-Kyung Lee; Jae-Woon Nah; Yun-Jaie Choi; Chong-Su Cho
Journal:  Biomaterials       Date:  2010-07-24       Impact factor: 12.479

2.  Sizing nanoparticle-covered droplets by extrusion through track-etch membranes.

Authors:  Ravisubhash Tangirala; Ravindra Revanur; Thomas P Russell; Todd Emrick
Journal:  Langmuir       Date:  2007-01-30       Impact factor: 3.882

3.  A hybrid nanoparticle probe for dual-modality positron emission tomography and magnetic resonance imaging.

Authors:  Jin-sil Choi; Jeong Chan Park; Hyunsoo Nah; Seungtae Woo; Jieun Oh; Kyeong Min Kim; Gi Jeong Cheon; Yongmin Chang; Jeongsoo Yoo; Jinwoo Cheon
Journal:  Angew Chem Int Ed Engl       Date:  2008       Impact factor: 15.336

Review 4.  Magnetic nanoparticles in MR imaging and drug delivery.

Authors:  Conroy Sun; Jerry S H Lee; Miqin Zhang
Journal:  Adv Drug Deliv Rev       Date:  2008-04-10       Impact factor: 15.470

5.  Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells.

Authors:  Udit N Verma; Rama M Surabhi; Aurelia Schmaltieg; Carlos Becerra; Richard B Gaynor
Journal:  Clin Cancer Res       Date:  2003-04       Impact factor: 12.531

6.  Preparation and characterization of protein C-loaded PLA nanoparticles.

Authors:  M F Zambaux; F Bonneaux; R Gref; E Dellacherie; C Vigneron
Journal:  J Control Release       Date:  1999-08-05       Impact factor: 9.776

7.  Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs.

Authors:  Jürgen Soutschek; Akin Akinc; Birgit Bramlage; Klaus Charisse; Rainer Constien; Mary Donoghue; Sayda Elbashir; Anke Geick; Philipp Hadwiger; Jens Harborth; Matthias John; Venkitasamy Kesavan; Gary Lavine; Rajendra K Pandey; Timothy Racie; Kallanthottathil G Rajeev; Ingo Röhl; Ivanka Toudjarska; Gang Wang; Silvio Wuschko; David Bumcrot; Victor Koteliansky; Stefan Limmer; Muthiah Manoharan; Hans-Peter Vornlocher
Journal:  Nature       Date:  2004-11-11       Impact factor: 49.962

8.  TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis.

Authors:  Stacey L Demento; Nathalie Bonafé; Weiguo Cui; Susan M Kaech; Michael J Caplan; Erol Fikrig; Michel Ledizet; Tarek M Fahmy
Journal:  J Immunol       Date:  2010-07-26       Impact factor: 5.422

9.  Species-specific urokinase receptor ligands reduce glioma growth and increase survival primarily by an antiangiogenesis mechanism.

Authors:  Xingyao Bu; Vazgen Khankaldyyan; Ignacio Gonzales-Gomez; Susan Groshen; Wei Ye; Shaoqiu Zhuo; Jaume Pons; Jennifer R Stratton; Steven Rosenberg; Walter E Laug
Journal:  Lab Invest       Date:  2004-06       Impact factor: 5.662

10.  Development and characterization of polymeric microspheres for controlled release protein loaded drug delivery system.

Authors:  S Ravi; K K Peh; Yusrida Darwis; B Krishna Murthy; T Raghu Raj Singh; C Mallikarjun
Journal:  Indian J Pharm Sci       Date:  2008 May-Jun       Impact factor: 0.975
View more
  21 in total

Review 1.  Potential prospects of nanomedicine for targeted therapeutics in inflammatory bowel diseases.

Authors:  Madharasi V A Pichai; Lynnette R Ferguson
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

2.  A(₂B)AR expression in non-immune cells plays an important role in the development of murine colitis.

Authors:  Sarah A Ingersoll; Hamed Laroui; Vasantha L Kolachala; Lixin Wang; Pallavi Garg; Timothy L Denning; Andrew T Gewirtz; Didier Merlin; Shanthi V Sitaraman
Journal:  Dig Liver Dis       Date:  2012-06-19       Impact factor: 4.088

3.  Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair.

Authors:  Giovanna Leoni; Philipp-Alexander Neumann; Nazila Kamaly; Miguel Quiros; Hikaru Nishio; Hefin R Jones; Ronen Sumagin; Roland S Hilgarth; Ashfaqul Alam; Gabrielle Fredman; Ioannis Argyris; Emile Rijcken; Dennis Kusters; Chris Reutelingsperger; Mauro Perretti; Charles A Parkos; Omid C Farokhzad; Andrew S Neish; Asma Nusrat
Journal:  J Clin Invest       Date:  2015-02-09       Impact factor: 14.808

4.  Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.

Authors:  Bo Xiao; Zhigang Xu; Emilie Viennois; Yuchen Zhang; Zhan Zhang; Mingzhen Zhang; Moon Kwon Han; Yuejun Kang; Didier Merlin
Journal:  Mol Ther       Date:  2017-01-28       Impact factor: 11.454

5.  Can naturally occurring nanoparticle-based targeted drug delivery effectively treat inflammatory bowel disease?

Authors:  Chunhua Yang; Didier Merlin
Journal:  Expert Opin Drug Deliv       Date:  2019-11-28       Impact factor: 6.648

Review 6.  Plant derived edible nanoparticles as a new therapeutic approach against diseases.

Authors:  Mingzhen Zhang; Emilie Viennois; Changlong Xu; Didier Merlin
Journal:  Tissue Barriers       Date:  2016-02-11

7.  Novel lansoprazole-loaded nanoparticles for the treatment of gastric acid secretion-related ulcers: in vitro and in vivo pharmacokinetic pharmacodynamic evaluation.

Authors:  Milind Alai; Wen Jen Lin
Journal:  AAPS J       Date:  2014-02-12       Impact factor: 4.009

8.  Vasoactive Intestinal Peptide Nanomedicine for the Management of Inflammatory Bowel Disease.

Authors:  Dulari Jayawardena; Arivarasu N Anbazhagan; Grace Guzman; Pradeep K Dudeja; Hayat Onyuksel
Journal:  Mol Pharm       Date:  2017-10-19       Impact factor: 4.939

Review 9.  Nanotechnology in diagnostics and therapeutics for gastrointestinal disorders.

Authors:  Hamed Laroui; Poonam Rakhya; Bo Xiao; Emilie Viennois; Didier Merlin
Journal:  Dig Liver Dis       Date:  2013-05-07       Impact factor: 4.088

10.  Natural-lipid nanoparticle-based therapeutic approach to deliver 6-shogaol and its metabolites M2 and M13 to the colon to treat ulcerative colitis.

Authors:  Chunhua Yang; Mingzhen Zhang; Sudeep Lama; Lixin Wang; Didier Merlin
Journal:  J Control Release       Date:  2020-04-23       Impact factor: 9.776
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.